Beneficient, a technology-enabled platform providing exit opportunities and primary capital solutions, has been granted a listing extension by Nasdaq.
The extension is subject to the Company's compliance with Nasdaq's periodic reporting requirement and bid price requirement within the granted period.
Beneficient is diligently working with its auditor to complete and file the Delayed Reports to meet the compliance criteria.
Listing Extension Granted
Beneficient received notification from Nasdaq for continued listing subject to compliance with reporting and bid price requirements.
Compliance Efforts Ongoing
The Company is actively working with its auditor to fulfill the compliance obligations within the extension period.
Potential Reverse Stock Split
In case of non-compliance with bid price requirements, Beneficient plans to seek stockholder approval for a reverse stock split.
- The listing extension provides Beneficient with additional time to meet Nasdaq's requirements, ensuring continued access to the stock market.
- Diligent efforts to comply with reporting standards reflect the Company's commitment to transparency and regulatory adherence.
Beneficient's proactive approach to addressing compliance issues demonstrates its dedication to maintaining its listing on Nasdaq. The Company's focus on meeting regulatory requirements and seeking shareholder approval for strategic decisions bodes well for its future operations.